ReviewFrontiers in endocrinology2025
Traditional Chinese medicine treatment strategies for primary dysmenorrhea.
Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Efficacy and safety of Dysmenorrhea Patch acupoint application in women with primary dysmenorrhea: a randomized double-blind controlled trial.Frontiers in endocrinology · 2026Trial
- Cai's gynecology cyclical therapy with stasis-clearing and meridian-warming method for primary dysmenorrhea: a randomized controlled trial.Frontiers in endocrinology · 2026Trial
- Clinical evidence on integrated Chinese-Western medicine for primary dysmenorrhea.Integrative medicine research · 2026Article
- Pharmacological Effects of Wenjing Decoction in a Rat Model of Cold Coagulation and Blood Stasis Primary Dysmenorrhea: An Integrated Analysis of Serum Pharmacochemistry, Network Pharmacology and Metabolomics.Pharmaceuticals (Basel, Switzerland) · 2026Article
- Herbal medicine as a complementary therapy for dysmenorrhea: effects on pain and reduction of analgesic use.Frontiers in medicine · 2026Article
- Case Report: Moxibustion-induced burns leading to disseminated methicillin-resistantFrontiers in endocrinology · 2026Article
- Ge-Gen Decoction Modulates the HSP90/AKT Signaling Pathway and the NLRP3 Inflammasome to Alleviate Primary Dysmenorrhea.Journal of pain research · 2026Article
- Clinical Evidence of Acupoint Stimulation for Primary Dysmenorrhea: A Systematic Review and Updated Meta-Analysis.Journal of pain research · 2025Review
- Ginger Moxibustion Activates TRPV1 to Modulate the Locus Coeruleus-Spinal Cord-Uterus Pathway and Alleviates Primary Dysmenorrhea in Rats.Journal of pain research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary dysmenorrhea is a common disease in women. China, under the influence of their philosophical wisdom, has developed unique theories of common clinical disorders and corresponding therapeutic cultural practices, including the application of unique medical wisdom to the treatment of primary dysmenorrhea. The article reviews the current Traditional Chinese medicine treatment strategies for primary dysmenorrhea, including acupuncture, moxibustion, acupoint application, diet improvement, and lifestyle adjustment. This article also analyzes the benefits and potential mechanisms of these treatments. Finally, this study highlights future directions for dysmenorrhea treatment, including ongoing research and potential new treatment modalities. This review aims to guide healthcare providers in developing the personalized treatment strategies for patients with primary dysmenorrhea and promote a more harmonious doctor-patient relationship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.